Study analysis · JMIR mHealth and uHealth · 2025
This fancy fitness app didn't help cancer patients recover—here's why your tech might be useless too.
Even though patients loved using the app, it didn't help them lose less weight or feel stronger than those who just got basic diet advice.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like a fair test where one group got a fancy app to help them eat and move better after surgery, and another group got regular advice. After a year, both groups ended up feeling and doing about the same. So, the app didn’t make people healthier — even though they liked using it.
What’s the bottom line?
Doctors gave some patients a smart app and wristband to track exercise and food after surgery, while others got regular advice. Both groups did fine.
How strong is this study?
This study was really well-made because it randomly assigned people to groups, followed them for a full year, and used good tools to measure results. That means we can trust that the app didn’t help — not because of bad design, but because the results are clear and fair.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
74 / 100
- Randomization+20/20
- Blindingnot blinded
- Control group+15/15
- Sample size (n=257)+14.5/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 579 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Although this is a randomized controlled trial, the lack of blinding and the absence of statistically significant differences in primary and most secondary outcomes limit the strength of causal inference. The study shows no benefit of the intervention over standard care, so causation is inferred in the negative direction (i.e., the intervention does not cause improvement), but not in the positive direction.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were explicitly stated in the provided text, and no industry affiliations or funder involvement were identified.
The study describes a digital intervention developed by Medi Plus Solution and uses their app and wearable device, but there is no explicit disclosure of funding, author affiliations with the company, or funder involvement in study design, analysis, or publication. Without a COI or funding statement, the absence of disclosure raises a potential transparency concern, though no direct conflict is confirmed.
Key takeaways
- 01
Both groups lost similar amounts of weight (around 5-10%) over 12 months.
- 02
People using the app liked it and used it often, but it didn’t help them gain muscle, lose fat, or feel better than those who just got standard advice.
- 03
Even though patients loved the app, it didn’t make them healthier or stronger — meaning just giving people tech tools isn’t enough if they’re already doing okay nutritionally.
Surprising findings
- High adherence (78.3% used the app regularly) did not translate into any measurable health improvement.We assume that if people use a health app often, it must be working—but here, usage was high and outcomes were flat. This flips the narrative that engagement equals efficacy.
- One statistically significant difference in nausea/vomiting (EORTC QLQ-C30) had identical medians and IQRs between groups.A p-value <.05 was found, but the actual symptom levels were the same—highlighting how statistical noise can be mistaken for real effects.
Practical takeaways
If you're a cancer survivor with normal BMI and no malnutrition, skip expensive digital rehab apps—stick to free, evidence-based dietary advice from your doctor.
This applies only to post-gastric cancer patients with preserved nutrition; those with low BMI or severe weight loss may still benefit.
high confidenceBefore investing in a health app, ask: 'Was this tested on people like me?' If the study population was healthier than you, the results may not apply.
Most apps don’t disclose their trial demographics—so demand transparency.
medium confidenceWhy this study matters
High Tech, Zero Results
Despite 78.3% of patients using the app and wearable device regularly over 12 months, there was no significant difference in weight loss, muscle mass, or quality of life compared to those receiving standard nutritional education. The average BMI was 24—well within normal range—suggesting most patients were already recovering well.
We assume tech = better health, but this study proves that if you're already doing okay, a fancy app won't make you healthier—just more monitored.
Satisfaction ≠ Effectiveness
Patients rated the app's effectiveness at 4.1/5 and usability at 4.0/5, yet these high satisfaction scores had zero correlation with actual health outcomes. Spearman correlation between app usage and weight change was ρ=0.054 (P=.56)—meaning no link.
Companies sell apps based on user happiness, but this study shows you can love something and still get no benefit. It’s a wake-up call for the entire digital health industry.
The Ceiling Effect Trap
Only 2 out of 257 patients had a BMI under 17—meaning nearly everyone was already well-nourished. The study suggests digital tools may only help those at high risk, not the 'average' patient.
Most health tech targets everyone—but this study proves it only works for the most vulnerable. We’re wasting billions on solutions for people who don’t need them.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Doctors gave some patients a smart app and wristband to track exercise and food after surgery, while others got regular advice. Both groups did fine.
Research results
Both groups lost similar amounts of weight (around 5-10%) over 12 months. People using the app liked it and used it often, but it didn’t help them gain muscle, lose fat, or feel better than those who just got standard advice.
What this means - more context
Even though patients loved the app, it didn’t make them healthier or stronger — meaning just giving people tech tools isn’t enough if they’re already doing okay nutritionally.
This study tested whether a personalized digital exercise and nutrition program improves postoperative outcomes in gastric cancer patients compared to standard nutritional education.
A 12-month personalized digital intervention using a smartphone app and wearable device was safe and well-adhered to but showed no significant benefit over standard care in weight change, body composition, physical fitness, nutritional status, or quality of life, despite high user satisfaction.
Methods Used
Multicenter randomized controlled trial with 257 postoperative gastric cancer patients (stage I-III) assigned 2:1 to a personalized digital intervention (app + wearable) or standard nutritional education; outcomes measured at baseline and 1, 3, 6, and 12 months.
Main Finding
No significant difference in weight change or secondary outcomes (body composition, physical fitness, nutritional status, quality of life) between the digital intervention and standard care groups; one minor EORTC QLQ-C30 subscale difference lacked clinical significance.
Confidence Level
High — large sample size, multicenter RCT with pre-registered design, intention-to-treat analysis, robust statistical methods including mixed-effects models and GEE, and consistent null findings across primary and secondary outcomes.
Study Flags
Red Flags
- •Study population had preserved baseline nutrition (mean BMI ~24), likely creating a ceiling effect
- •No adjustment for multiple comparisons in secondary outcomes
- •Open-label design with potential for performance bias
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
High adherence (78.3% used the app regularly) did not translate into any measurable health improvement.
We assume that if people use a health app often, it must be working—but here, usage was high and outcomes were flat. This flips the narrative that engagement equals efficacy.
Practical Takeaways
If you're a cancer survivor with normal BMI and no malnutrition, skip expensive digital rehab apps—stick to free, evidence-based dietary advice from your doctor.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 579 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study is like a fair test where one group got a fancy app to help them eat and move better after surgery, and another group got regular advice. After a year, both groups ended up feeling and doing about the same. So, the app didn’t make people healthier — even though they liked using it.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Randomized controlled trial design with high confidence in randomization
- Large sample size (n=257) with intention-to-treat analysis
- Long follow-up period (12 months)
Weaknesses
- Open-label design with no blinding, introducing performance and detection bias
- Baseline imbalances in age, alcohol use, chemotherapy, and grip strength not fully adjusted for
- Underpowered for secondary outcomes due to sample size calculation focused only on primary outcome
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Doctors gave some patients a smart app and wristband to track exercise and food after surgery, while others got regular advice. Both groups did fine.
Research results
Both groups lost similar amounts of weight (around 5-10%) over 12 months. People using the app liked it and used it often, but it didn’t help them gain muscle, lose fat, or feel better than those who just got standard advice.
What this means - more context
Even though patients loved the app, it didn’t make them healthier or stronger — meaning just giving people tech tools isn’t enough if they’re already doing okay nutritionally.
This study tested whether a personalized digital exercise and nutrition program improves postoperative outcomes in gastric cancer patients compared to standard nutritional education.
A 12-month personalized digital intervention using a smartphone app and wearable device was safe and well-adhered to but showed no significant benefit over standard care in weight change, body composition, physical fitness, nutritional status, or quality of life, despite high user satisfaction.
Methods Used
Multicenter randomized controlled trial with 257 postoperative gastric cancer patients (stage I-III) assigned 2:1 to a personalized digital intervention (app + wearable) or standard nutritional education; outcomes measured at baseline and 1, 3, 6, and 12 months.
Main Finding
No significant difference in weight change or secondary outcomes (body composition, physical fitness, nutritional status, quality of life) between the digital intervention and standard care groups; one minor EORTC QLQ-C30 subscale difference lacked clinical significance.
Confidence Level
High — large sample size, multicenter RCT with pre-registered design, intention-to-treat analysis, robust statistical methods including mixed-effects models and GEE, and consistent null findings across primary and secondary outcomes.
Study Flags
Red Flags
- •Study population had preserved baseline nutrition (mean BMI ~24), likely creating a ceiling effect
- •No adjustment for multiple comparisons in secondary outcomes
- •Open-label design with potential for performance bias
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
High adherence (78.3% used the app regularly) did not translate into any measurable health improvement.
We assume that if people use a health app often, it must be working—but here, usage was high and outcomes were flat. This flips the narrative that engagement equals efficacy.
Practical Takeaways
If you're a cancer survivor with normal BMI and no malnutrition, skip expensive digital rehab apps—stick to free, evidence-based dietary advice from your doctor.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 579 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study is like a fair test where one group got a fancy app to help them eat and move better after surgery, and another group got regular advice. After a year, both groups ended up feeling and doing about the same. So, the app didn’t make people healthier — even though they liked using it.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Randomized controlled trial design with high confidence in randomization
- Large sample size (n=257) with intention-to-treat analysis
- Long follow-up period (12 months)
Weaknesses
- Open-label design with no blinding, introducing performance and detection bias
- Baseline imbalances in age, alcohol use, chemotherapy, and grip strength not fully adjusted for
- Underpowered for secondary outcomes due to sample size calculation focused only on primary outcome
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study was really well-made because it randomly assigned people to groups, followed them for a full year, and used good tools to measure results. That means we can trust that the app didn’t help — not because of bad design, but because the results are clear and fair.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
74 / 100
- Randomization+20/20
- Blindingnot blinded
- Control group+15/15
- Sample size (n=257)+14.5/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 579 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Although this is a randomized controlled trial, the lack of blinding and the absence of statistically significant differences in primary and most secondary outcomes limit the strength of causal inference. The study shows no benefit of the intervention over standard care, so causation is inferred in the negative direction (i.e., the intervention does not cause improvement), but not in the positive direction.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were explicitly stated in the provided text, and no industry affiliations or funder involvement were identified.
The study describes a digital intervention developed by Medi Plus Solution and uses their app and wearable device, but there is no explicit disclosure of funding, author affiliations with the company, or funder involvement in study design, analysis, or publication. Without a COI or funding statement, the absence of disclosure raises a potential transparency concern, though no direct conflict is confirmed.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
9 researchersIf this is your work, this is how we attribute it on Fit Body Science. Inah Kim is listed as the lead author.